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A B S T R A C T
There is considerable need to develop tailored approaches to psychiatric treatment. Numerous researchers have
proposed using functional magnetic resonance imaging (fMRI) biomarkers to predict therapeutic response, in
particular by measuring task-evoked subgenual anterior cingulate (sgACC) and amygdala activation in mood
and anxiety disorders. Translating this to the clinic relies on the assumption that blood-oxygen-level dependent
(BOLD) responses in these regions are stable within individuals. To test this assumption, we scanned a group of
29 volunteers twice (mean test-retest interval=14.3 days) and calculated the within-subject reliability of the
amplitude of the amygdalae and sgACC BOLD responses to emotional faces using three paradigms: emotion
identiﬁcation; emotion matching; and gender classiﬁcation. We also calculated the reliability of activation in a
control region, the right fusiform face area (FFA). All three tasks elicited robust group activations in the
amygdalae and sgACC (which changed little on average over scanning sessions), but within-subject reliability
was surprisingly low, despite excellent reliability in the control right FFA region. Our ﬁndings demonstrate low
statistical reliability of two important putative treatment biomarkers in mood and anxiety disorders.
Introduction
Neuropsychiatric disorders are debilitating and common, and many
patients fail to respond to their ﬁrst treatment, with a substantial
minority going on to experience chronic symptoms (Simon et al.,
2006). Unlike in many branches of medicine, no useful biomarkers
exist to predict treatment response in psychiatry. Instead, choosing the
appropriate treatment for a speciﬁc patient typically involves a
combination of clinical judgment and trial-and-error. Previous work
suggests that neuroimaging may be useful in predicting treatment
response to a variety of treatments for depression (Roiser et al., 2012),
including cognitive behavioural therapy (Siegle et al., 2006), antide-
pressant medication (Brockmann et al., 2009; Keedwell et al., 2009),
transcranial magnetic stimulation (Downar et al., 2013) and sleep
deprivation (Ebert et al., 1991). An implicit assumption of studies
using fMRI to identify treatment biomarkers is that, within an
individual, the amplitude of the task-evoked blood-oxygen-level de-
pendent (BOLD) response is stable over time (Fournier et al., 2014).
That is, the signal evoked by a given task in a given region on one day
should be evoked to a similar degree on another day. Such stability of
measurement is essential in the interpretation of results. If a putative
treatment biomarker is not reliable (at the level of the individual), it is
unlikely to be useful as a predictor of clinical outcome.
Two regions in particular have emerged as strong candidates for
fMRI biomarkers in depression treatment: the anterior cingulate
cortex, particularly the rostral and subgenual (sgACC) portions, and
the amygdala. Preliminary work in small samples has indicated that
pre-treatment activation in the perigenual anterior cingulate cortex
(ACC; including rostral and sgACC), particularly during emotion
processing, may predict response to standard antidepressant treatment
(Keedwell et al., 2009, 2010, Chen et al., 2007, Davidson et al., 2003).
Pre-treatment perigenual ACC deactivation to negative stimuli has
been reported to predict worse response to antidepressant treatment
with two diﬀerent medications, ﬂuoxetine (Chen et al., 2007) and
venlafaxine (Davidson et al., 2003). By contrast, in other studies sgACC
deactivation to negative stimuli predicted better response to cognitive
behavioural therapy (Siegle et al., 2006) and behavioural activation
therapy (Dichter et al., 2010). Heightened amygdala activation during
inhibitory control (Langenecker et al., 2007) and negative information
processing (Siegle et al., 2006, 2007) has also been reported to predict
response to both antidepressant medication and cognitive behavioural
therapy (CBT).
Various fMRI cognitive activation paradigms have been used to
identify putative treatment biomarkers in depression, most commonly
using emotional faces (Keedwell et al., 2009, 2010, Frodl et al., 2010,
Fu et al., 2008a, 2008b). Despite robust activation when averaging
across individuals, and evidence that activation can diﬀerentiate
responder and non-responder groups (Keedwell et al., 2009, 2010,
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Langenecker et al., 2007, Fu et al., 2008b), many studies acknowledge
that clinically relevant prognostic markers require high predictive
accuracy at the level of the individual (Fu et al., 2013). To achieve
this, the reliability of BOLD responses must be good. Several previous
studies have examined the test-retest reliability of amygdala activation
during emotional face processing (Johnstone et al., 2005, Sauder et al.,
2013, Manuck et al., 2007, Lipp et al., 2014), reporting a range of
reliabilities, ranging from near 0 (no reliability) (Plichta et al., 2012) to
0.5–0.6 (moderate–to-good reliability) (Johnstone et al., 2005,
Manuck et al., 2007). However, these studies only administered a
single emotion processing task, leaving open the possibility that
diﬀerent tasks may evoke BOLD activation with varying reliability.
The reliability of sgACC activation at the subject level has never been
reported to our knowledge, despite the promising preliminary results
discussed above.
Therefore, we sought to measure the reliability of activation in the
amygdala and sgACC across two scan days, as well as within the same
session (between runs, approximately 10 min apart). Based on the
higher number of reports of prediction of treatment response in
depression from sgACC than amygdala activation, we hypothesised
that reliability would be higher in the sgACC than in the amygdala. We
employed three well-established emotional face processing tasks, which
allowed us explore the relative reliability of activation they evoked.
Thus, we aimed to establish whether sgACC or amygdala activation
during emotional face processing could potentially serve as treatment
biomarkers, as well as examining the eﬀect of paradigm selection on
inter- and intra-session reliability.
Methods and materials
Participants
Twenty-nine right-handed participants, 18–40 years of age (10
males) and ﬂuent in English, were recruited through the UCL Institute
of Cognitive Neuroscience subject database. Exclusion criteria included
history of any neurological or mental health conditions. All participants
were screened for current or past psychiatric disorders using the Mini
International Neuropsychiatric Interview, version 5.0.0 (Sheehan et al.,
1998). Additionally, illegal substance use was prohibited in the six
weeks preceding the ﬁrst MRI scan, and standard MRI safety restric-
tions applied. We initially recruited 35 participants, but six participants
were excluded from the ﬁnal analysis: four because they did not return
for the second MRI scan, and two because their MRI data were lost.
The ﬁnal sample had a mean age of 26 (SD=6.24) and consisted of
nineteen female participants. Participants were compensated £30 for
both sessions. The study was approved by the UCL Departmental
Research Ethics Committee (ID: fMRI/2013/005).
Experimental paradigm
Subjects were tested on three separate days. The ﬁrst day involved
initial screening for psychiatric conditions and MRI contraindications
and a practice session of each task, in order to decrease the novelty of
the stimuli and ensure participants understood all task instructions. On
the second and third testing days, which occurred 9–21 days later
(mean time between scans=14.33 days (SD=2.10)), participants per-
formed each task twice in the scanner, with the order consistent
between days (including the practice day) and counterbalanced be-
tween participants. Subjects used an MRI-compatible button box to
make responses during the tasks.
We employed the following three tasks: emotion identiﬁcation,
emotion matching, and gender classiﬁcation (see Table 1). All face
stimuli were sourced from the NimStim Face Stimulus Set (http://
www.macbrain.org/resources.htm) (Tottenham et al., 2009).
Emotion identiﬁcation task (Robinson et al., 2012)
Emotional face stimuli lasting 1 s were followed by a jittered (3–5 s)
centrally-presented ﬁxation cross in a task adapted from a recent study
(Robinson et al., 2012). Sixty stimuli were presented in total. There was
a baseline period of ﬁxation lasting 30 s at the beginning and end of the
task. Subjects identiﬁed the emotion of the face presented as happy,
fearful, or neutral, using an MRI-compatible button box with index,
middle, and ring ﬁnger presses corresponding to happy, fearful, and
neutral faces, respectively. Each participant was presented with a
random order of male and female faces, with an equal proportion of
male and female faces. We analysed the accuracy of emotion identiﬁca-
tion (data not shown) and excluded two subjects because of non-
responses on more than 20 trials (indicating that they were not
attending to the task); the ﬁnal analysis included 27 participants.
Emotion matching task (Hariri et al., 2002)
Participants viewed faces displaying angry or fearful emotions,
matching the emotion of a centrally-presented face to one of two
alternatives presented at the bottom left and bottom right of the screen.
The control condition involved matching a central shape with one of
two test shapes. In both conditions, participants pressed their index
ﬁnger for central stimuli that matched the bottom left stimulus, and
their middle ﬁnger for central stimuli that matched the bottom right
stimulus. Each participant was presented with a random order of male
and female faces, with an equal proportion of male and female faces.
Three blocks of shape matching and two blocks of emotion matching
were performed in each run of the task, with all stimuli presented for
5 s. There were six trials in each of the ﬁve blocks, with each block
lasting 30 s. We analysed the accuracy of both shape and emotion
matching (data not shown). No subjects were excluded because of poor
task performance (N=29).
Gender classiﬁcation task (O’Nions et al., 2011)
Participants viewed faces displaying happy, fearful, and neutral
emotions, and were instructed to classify the gender of each face.
Participants were instructed to press their index ﬁnger to respond to
female faces, and their middle ﬁnger to respond to male faces. Each
participant was presented with a random order of male and female
faces, with an equal proportion of male and female faces. The task was
made up of twelve blocks, each consisting of a single emotion, with
eight stimuli per block; each emotional condition block occurred four
times in each run. Faces were displayed for 2 s, with each block lasting
16 s. Between each block, a central ﬁxation cross was displayed for
16 s. We analysed the accuracy of gender classiﬁcation (data not
shown), and excluded one subject with performance worse than
chance; the ﬁnal analysis included 28 participants.
Image acquisition and analysis
We acquired gradient-echo T2*-weighted images using a Siemens
Avanto 1.5 T MRI scanner (32-channel head coil), with 36 slices per
volume, and a slice gap of 1 mm (50% distance factor; 2 mm slices). We
Table 1
Characteristics of each task.
Emotion
matching
Emotion
identification
Gender
classification
Task duration
(per run)
5:55 4:03 6:24
Task design Blocked Event-related Blocked
Regressors of
interest
Faces; shapes Happy; fearful;
neutral
Happy; fearful;
neutral
Regressors of no
interest
6 movement
parameters
6 movement
parameters
6 movement
parameters+errors
Contrast Faces > shapes Faces > fixation Faces > fixation
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employed a highly optimized pulse sequence with a 32-channel head
coil. The 32-channel coil improves SNR up to 3.5 times (Wiggins et al.,
2006) compared to the standard 8 or 12 channel coil. In addition,
susceptibility artefacts (i.e. signal dropout) in the regions of interest in
our study are substantially increased at higher ﬁeld strengths. Note,
however, that the high spatial resolution provided by ultra-high ﬁeld
fMRI can mitigate the negative inﬂuences of physiological noise
sources on ventral brain areas: previous work has reported a clear
gain in percent signal change during facial emotion discrimination at
7 T (compared to 3 T) MRI (Sladky et al., 2013).
For each echo planar imaging (EPI) sequence, we used a 30° tilted
sequence to minimize dropout in the ventral prefrontal cortex and
amygdalae (O’Nions et al., 2011, Weiskopf et al., 2006). This acquisi-
tion protocol was developed by testing the optimal parameters to
reduce susceptibility-induced BOLD sensitivity losses in the ventral
prefrontal cortex (Weiskopf et al., 2006). Brieﬂy, magnetic suscept-
ibility varies greatly between tissue and air cavities and this variation
can induce localised magnetic ﬁeld gradients which interfere with the
imaging ﬁeld gradients causing distortion and loss of signal. The
protocol optimized the phase encoded direction gradient polarity and
slice orientation, such that signal losses due to induced ﬁeld gradients
within-slice, in the phase encoded direction, are small enough not to
cause signal loss; and employed a "z-shimming" gradient prepulse to
counteract signal loss from through-slice induced magnetic ﬁeld
gradients. However, this optimized sequence also gave us reduced
coverage of the brain. For this reason, we include our second-level
mask in the Supplemental materials (see Figure S1, A–C).
Echo time was 50 ms, repetition time per slice was 87 ms, slice
thickness was 2 mm, and in-plane resolution was 2×2 mm. We
acquired one ﬁeldmap per subject per day with identical parameters
to the EPI scans, and one ﬁve-minute magnetization-prepared rapid
gradient-echo T1-weighted 1 mm isotropic anatomical scan for each
subject.
EPI data were analysed using Statistical Parametric Mapping
(SPM12; Wellcome Trust Centre for Neuroimaging, London, www.ﬁl.
ion.uck.ac.uk/spm) in Matlab R2015a. Due to the relatively long TR (3.
132 s), we performed slice-time correction on all data to minimize
diﬀerences over time in slice acquisition. After removing the ﬁrst six
volumes from each time series to allow for T1 equilibration, the
remaining volumes were realigned to the seventh volume,
coregistered to each subject's anatomical scan, normalized into
standardized space (Montreal Neurological Institute template), and
smoothed using an 8 mm full width at half maximum Gaussian kernel.
Following the realignment stage, all image sequences were checked for
movements greater than 1.5 mm or rotations greater than 1 degree in
any direction – corrupted images were removed and replaced using
interpolation. Following normalization, anatomical images were
manually checked for artefacts.
Regressors of interest (see Table 1) were convolved with SPM's
canonical synthetic hemodynamic response function time-locked to the
onset of the corresponding event. We included six movement regres-
sors of no interest in all subjects, and an error regressor of no interest
only in subjects who made errors on the gender classiﬁcation task. In
the gender classiﬁcation and emotion identiﬁcation tasks, ﬁxation
periods constituted an implicit baseline. Using the general linear
model, parameter estimate images were estimated for each regressor,
and combined to create the primary contrast of interest for each task
(for gender classiﬁcation and emotion identiﬁcation, faces vs ﬁxation;
for emotion matching, faces vs shapes).
Second-level analyses were conducted using the standard summary
statistics approach to random eﬀects analysis. We anticipated that we
would identify amygdala activation (faces > ﬁxation) and sgACC deac-
tivation (ﬁxation > faces) while viewing emotional faces. We identiﬁed
the group-level peak voxel for each task's primary contrast, averaged
across runs and days, in the left amygdala, right amygdala, and sgACC
(see Table 2). We applied a cluster-forming threshold of p < 0.001
(uncorrected) and report small volume corrected p-values for re-
sponses in the amygdalae and sgACC at the voxel- and cluster-levels
in Table 2.
Functional ROI approach
There are two main approaches to calculating the within-subject
test-retest reliability of fMRI: (1) extracting values from group-level
peaks; (2) using a priori deﬁned regions (Aron et al., 2006). We ﬁrst
employed approach 1: for the purpose of calculating reliability statis-
tics, we created functional regions of interest (ROIs) separately for each
task. We extracted parameter estimates for each subject from the left
amygdala, right amygdala, and sgACC using a 4 mm sphere centered on
each group-level peak voxel for the primary contrast from the relevant
task. Anatomical masks from the PickAtlas toolbox were applied to
conﬁrm that the peak voxels fell within these structures; sgACC was
deﬁned as Brodmann Areas 24 and 25. Note that all of the contrasts
used to identify activations (averaged across days and runs) are
orthogonal to the analyses on which we make inference (eﬀects of
day and run; correlations between days and runs), thus avoiding non-
independence error. We repeated this procedure for a second contrast,
fearful > neutral faces, but failed to identify robust activation in these
regions. We therefore do not report reliability statistics for this
contrast.
We also calculated reliability statistics for a fourth region, the right
fusiform face area (FFA), which served as a positive control. This
allowed us to test the general reliability of our experimental design. To
do this, we extracted parameter estimates for each subject from the
right FFA using a 4 mm sphere centred on the right FFA coordinates
reported in a previous publication (McKeeﬀ and Tong, 2007) (MNI
coordinates: 38, −43, −20). We repeated this procedure for the faces vs
control contrast for each of the three tasks. For these analyses, we
excluded subjects in whom coverage did not include the FFA (N=4); see
Table 2 for group-level peak voxels within the fusiform gyrus, and
Figure S1, D–F for the second-level masks.
Anatomical ROI approach
We also employed a second approach, using anatomically-deﬁned
ROIs to calculate reliability. For the amygdalae, we used masks from
the PickAtlas toolbox. For the sgACC, we manually deﬁned the volume
on a representative participant's anatomical MRI using the borders and
deﬁnition reported in previous probabilistic maps, which included
several distinct cyto- and receptor-architectonic areas: 25, s24, s32,
and the ventral portion of area 33 (Palomero-Gallagher et al., 2015).
Reliability analysis
Subject-level parameter estimates (averaged across all voxels in
ROIs) were extracted from SPM for each task, ROI and scanning
session, and analysed with the Statistical Package for the Social
Sciences 22 (http://www.ibm.com/analytics/us/en/technology/spss/).
First, to test the eﬀects of day and run on BOLD responses, we ran nine
repeated measures analyses of variance (ANOVAs) on the extracted
subject-level activations, for each task and ROI. Alpha=0.05 was set as
the signiﬁcance threshold.
To test our primary hypothesis, we calculated intra-class correlation
coeﬃcients (ICCs) for each ROI (left amygdala, right amygdala, sgACC,
and our control region, right FFA) between the two scan days, using the
average of the two runs on each day. We repeated this ICC analysis to
test the reliability within each scan day (between the two runs). To test
whether the ﬁrst or second run of each day contributed particularly to
reliability, we also calculated ICCs between the ﬁrst and second runs
separately between the two days (i.e., the reliability run 1 of day 1 and
run 1 of day 2; and the reliability run 2 of day 1 and run 2 of day 2).
The ICC is a standard method to quantify the stability of measure-
ments between test and retest sessions (Bennett and Miller, 2010).
Most versions of the ICC are interpreted as a ratio of variances (Bartko,
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1966), with ICCs approaching 1.0 indicating near-perfect agreement
between the values of the test and retest measurements, and ICCs
approaching 0 indicating little or no reliability. We assessed reliability
using ICC(3,1), a 2-way mixed eﬀects ICC, deﬁned by Shrout and Fleiss
(Shrout and Fleiss, 1979) as:
ICC BMS EMS BMS k EMS(3, 1) = − / + ( − 1)*
Where BMS=between-subjects mean square; EMS=error mean square;
Table 2
fMRI results for activation to all faces in the relevant regions of interest.
Region Task Coordinates (x,y,z) Z-score k (cluster size) p value (cluster-level corrected) p value (voxel-level corrected)
sgACC GC 6,35,5 5.52 152 < 0.001 < 0.001
EI 6,38,2 4.84 80 < 0.001 < 0.001
EM −3,17,−7 5.12 43 0.001 0.001
Left amygdala GC −24 −7 −13 5.75 47 0.001 < 0.001
EI −21,−4,−13 4.78 31 0.001 < 0.001
EM −21,−7,−16 5.11 59 < 0.001 < 0.001
Right amygdala GC 21,−4,−16 5.59 50 0.001 < 0.001
EI 21,−1,−13 4.58 28 0.001 < 0.001
EM 21,−4,−13 6.19 63 < 0.001 < 0.001
Control region
Right FFA GC 33, −37, −19 4.60 26 0.009 < 0.001
EI 39,−55,−25 5.96 53 0.001 < 0.001
EM 30,−46,−13 4.34 4 0.062 0.001
Cluster-forming threshold p=0.001 uncorrected, restricted to the relevant anatomical mask (sgACC, left amygdala; right amygdala; right fusiform gyrus); p-values are family-wise error
small volume corrected (SVC). sgACC=subgenual anterior cingulate cortex. GC=gender classiﬁcation; EI=emotion identiﬁcation; EM=emotion matching. For the control region only,
reliability analyses used the same coordinate (from a previous publication, (McKeeﬀ and Tong, 2007)) for extracting activation across all tasks.
Fig. 1. Whole-brain activation maps and parameter estimates for the three functionally-deﬁned regions of interest (left and right amygdala, and subgenual anterior cingulate cortex,
sgACC), and the comparison region, the right fusiform face area (FFA), for all runs (both days). Coloured arrows and stars indicate coordinates used in the analysis: cyan arrows
correspond to peak activation in the left amygdala; green arrows to peak activation in the right; yellow arrows indicate the coordinate from a previous study (McKeeﬀ and Tong, 2007)
used for the FFA analysis; magenta arrows indicate peak activation in the sgACC. Images were thresholded at p < 0.001 (uncorrected) and at the minimum cluster size surviving whole-
brain cluster-level correction for each contrast; the heat bars indicate t-values. Please see Table 2 for statistics. A, E, I: faces vs ﬁxation (1) and faces vs shapes (1) include all subjects;
faces vs ﬁxation (2) and faces vs shapes (2) (B, F, J) exclude the four subjects whose FFA was not included in the mask. Asterisk over the EM (*) bar chart depicts the only main or
interaction eﬀect of day or run: the eﬀect of day on sgACC activation (p=0.045).
C.L. Nord et al. NeuroImage 156 (2017) 119–127
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k=number of repeated sessions (i.e., 2).
In our analyses, this form of the ICC indicates the correlation
between BOLD response parameter estimates between sessions, and
has been used in previous studies assessing the test-retest reliability of
amygdala activation (Plichta et al., 2012, Johnstone et al., 2005, Sauder
et al., 2013, Manuck et al., 2007, Lipp et al., 2014). Of note, in this ICC,
the eﬀect of measure (i.e., the scanner) is assumed to be ﬁxed rather
than random, while the eﬀects of subjects are assumed to be random.
We employ a “consistency” measure of ICC, rather than testing the
absolute agreement between days or runs, due to the possibility that
participants might habituate to the stimuli over time. Thus, a high ICC
implies that the relative activations are consistent between days (i.e.,
the subjects with greater activation on day 1, relative to the rest of the
group, are also those with greater activation on day 2). We report
average measures ICC statistics as the calculation of parameter
estimates in fMRI inherently involves averaging over many trials.
We adhere to a conventional interpretation of ICCs to quantify the
degree of reliability: ICC < 0.4 = poor reliability; 0.4–0.75=moderate to
good reliability; > 0.75=excellent reliability (Fleiss, 1986, Plichta et al.,
2012). A negative ICC is usually interpreted as a reliability of zero
(Bartko, 1976), since the theoretical limits of the ICC are 0–1 (although
negative values can occur, when the within-groups variance exceeds the
between group variance, this is outside the theoretical range (Lahey
et al., 1983)). Statistical signiﬁcance was of secondary concern in the
reliability analysis, but we also report p-values for all reliable activa-
tions, and 95% conﬁdence intervals for all ICCs, obtained from an F-
test against the null hypothesis.
We calculated that 27 participants would be needed to achieve 80%
power to detect an eﬀect size (correlation) of r=0.5 (at alpha=0.05),
with 0.5 chosen as it represents a potentially clinically meaningful
degree of reliability.
Results
Average activation
As expected, all tasks induced signiﬁcant activation (surviving
whole-brain correction for multiple comparisons) in the left and right
amygdalae, and deactivation in the sgACC (Fig. 1 and Table 2). For
each task, we conducted a two-way repeated measures ANOVA, for
each functional ROI (left amygdala, right amygdala, and sgACC –
average values across voxels in functional ROIs), examining the eﬀects
of day and run on activation. No main or interaction eﬀects reached
signiﬁcance in the emotion identiﬁcation task (Fig. 1D) or the gender
classiﬁcation task (Fig. 1L). In the emotion matching task (Fig. 1H), the
sgACC deactivated more on the ﬁrst day than on the second (F(1,28)
=4.415, p=0.045), but there was no main eﬀect of run or day-by-run
interaction (both p > 0.5), and no main eﬀects or interactions in the
other two ROIs reached signiﬁcance. See Supplemental information for
full statistics (Table S1), and Fig. 1 for whole-brain activation maps and
parameter estimates for the three functional ROIs, with the control
region, right FFA, presented for comparison purposes.
We repeated these analyses for the anatomically-deﬁned ROIs. No
main or interaction eﬀects reached signiﬁcance in the emotion
identiﬁcation task (Figure S2A; Table S1). There was a signiﬁcant
eﬀect of day on sgACC response in the emotion matching task (F(1,28)
=5.141, p=0.031) (Figure S2B), and gender classiﬁcation task (F(1,26)
=5.366, p=0.029) (Figure S2C): again, the sgACC deactivated more on
the ﬁrst day than on the second. There was also an interaction between
day and run on sgACC response in the emotion matching task (F(1,28)
=5.573, p=0.025): on the ﬁrst day, the sgACC deactivated more on the
second run; on the second day, it deactivated more on the ﬁrst run
(Figure S2B). No other main or interaction eﬀects reached signiﬁcance.
See Supplemental information for full statistics (Table S1) and ﬁgures
(Figure S2).
Post-hoc exploratory interactions with sex
We also examined whether participant sex interacted with mea-
sured activation in the amygdalae and sgACC in any of the three tasks.
We ran these analyses for each task and region, ﬁrst for the function-
ally-deﬁned ROIs, examining the interaction between day and sex,
between run and sex, and the three-way interaction between day, run,
and sex (45 statistics in total: see Supplemental information Table S2).
No regions or tasks showed any interaction with sex, with the exception
of right amygdala activation in the emotion identiﬁcation task, where
there was a run-by-sex interaction (F(1,24)=5.401, p=0.029); however,
most relevant for our analyses, there was no interaction with day, nor a
three-way interaction between sex, run, and day.
We repeated this analysis for the anatomically-deﬁned ROIs. In the
emotion matching and gender classiﬁcation tasks, no region showed
any interaction with sex. In the emotion identiﬁcation task, there was
no interaction between sex and day, nor between sex, day, and run, but
all three regions showed a run-by-sex interaction (left amygdala:
F(1,25)=6.330, p=0.019, right amygdala: F(1,25)=7.921, p=0.009,
sgACC: F(1,25)=4.796, p=0.038). For all three regions, this was driven
by a reduction in activation (corresponding to an increase in deactiva-
tion in the sgACC) between run 1 and run 2 in male participants (on
both days); female participants, by contrast, typically showed a small
increase in activation (decrease in sgACC deactivation) between the two
runs (data not shown).
Within-subject reliability of activation (functional ROI analysis)
Between-day reliability
We examined the reliability of activation within each subject, across
the two days. In most cases, between the ﬁrst and second days
(averaging across both runs on each day) the amplitude of BOLD
responses showed poor reliability: the majority of ICCs we observed—
seven out of nine reliability statistics— were well below 0.4 (see
Table 3). In the gender classiﬁcation task, both left amygdala
(ICC=0.418, p=0.087, 95%CI=−0.278 to 0.735) and sgACC (0.460,
p=0.061, 95%CI=−0.185 to 0.754) just exceeded the threshold for
moderate reliability (0.4), see Fig. 2. We did not ﬁnd any relationship
between the stability of each participant's BOLD response between
days (in any task or any region) and state or trait anxiety: see
Supplemental analysis S1.
Separately examining the reliability of responses during the ﬁrst
and second runs of each task between days again revealed no instances
of reliability in the emotion identiﬁcation task, or in the emotion
matching task, but three (out of 18) instances of moderate-to-good
reliability in the gender classiﬁcation task: reliability exceeded 0.4 in
the sgACC between the ﬁrst runs of each day (ICC=0.473, p=0.054,
95%CI=−0.156 to 0.760), and in the left (ICC=0.575, p=0.017, 95%
CI=0.066–0.806) and right amygdala (ICC=0.552, p=0.023, 95%
CI=0.018–0.796) in the second runs of each day.
There were no other reliable activations on any of the three tasks,
either averaging across runs or examining them separately.
Within-day reliability
Most tasks also showed poor within-day reliability (i.e., the
reliability of activation in run 1 versus run 2 on the same day). There
were three exceptions (of 18 tests), all on the second day: in the
emotion identiﬁcation task, the right amygdala showed moderate
reliability (ICC=0.450, p=0.067, 95%CI=−0.206 to 0.750), and in the
gender classiﬁcation task, both left (ICC=0.671, p=0.003, 95%
CI=0.278–0.850) and right (ICC=0.770, p < 0.001, 95%CI=0.495–
0.895) amygdalae showed very good reliability. No other task evoked
reliable within-day responses in any of the three ROIs.
Reliability of control region
We repeated these analyses for our control region, the right FFA
(see Table 3). In almost all cases (13/15 tests), the right FFA showed at
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least moderately reliable activations, both between and within-day. In
the two block design tasks, emotion matching and gender classiﬁcation,
the right FFA showed excellent reliability in every instance (all ICC >
0.75; all p < 0.001), in both within-day and between-day analyses. In
the event-related emotion identiﬁcation task, the right FFA showed
moderate-to-good reliability (ICC > 0.4) between days overall, as well
as between days in the ﬁrst runs, and across runs on the ﬁrst day.
However, in this task we found poor reliability between the second runs
of each day (ICC=0.180, p=0.319, 95%CI=−0.896 to 0.645), and within
the second day, across runs (ICC=0.292, p=0.207, 95%CI=−0.636 to
0.694).
Within-subject reliability of activation (anatomical ROI analysis)
Between-day reliability
For our secondary reliability analysis, we used the values extracted
from the anatomical ROIs to examine the reliability of activation within
each subject, across the two days. See Table 4 for full statistics. In this
case, between the ﬁrst and second days (averaging across both runs on
each day) the amplitude of BOLD responses showed low reliability in
six out of nine analyses. Two exceptions were in the sgACC: for the
emotion identiﬁcation task (ICC=0.564, p=0.019, 95%CI=0.043–
0.801) and for the gender classiﬁcation task (ICC=0.577, p=0.016,
95%CI=0.073–0.807); one was in the left amygdala, for the emotion
matching task: (ICC=0.432, p=0.07, 95%CI=−0.210 to 0.733).
Separately examining the reliability of responses during the ﬁrst
and second runs of each task between days also revealed low reliability
in 16 out of 18 analyses, with two exceptions, both in the sgACC: the
reliability of the second runs of the emotion identiﬁcation task
(ICC=0.524, p=0.032, 95%CI=−0.045 to 0.783) and the ﬁrst runs of
the emotion matching task (ICC=0.445, p=0.066, 95%CI=−0.197 to
0.744).
Within-day reliability
The majority of comparisons showed poor within-day reliability
(i.e., the reliability of activation in run 1 versus run 2 on the same day).
There were ﬁve exceptions (out of 18 analyses): the sgACC on the ﬁrst
day in all three tasks: the emotion identiﬁcation task (ICC=0.445,
p=0.07, 95%CI=−0.217 to 0.747), the emotion matching task
(ICC=0.659, p=0.003, 95%CI=0.274—0.840), and the gender classiﬁ-
Table 3
Intra-subject reliability statistics for all tasks and contrasts (functional ROIs and control region).
Task Contrast Reliability LAmyg ICC (95% CI) RAmyg ICC (95% CI) sgACC ICC (95% CI) FFA ICC (95% CI)
EI Faces> ﬁxation Between-day (both runs) 0.033 (−1.122 to 0.559) −0.382 (−2.032 to 0.370) −0.834 (−3.025 to 0.164) 0.547 (−0.470 to 0.804)*
Between-day (run 1) 0.304 (−0.527 to 0.683) 0.211 (−0.731 to 0.641) −0.753 (−2.847 to 0.201) 0.456 (−0.258 to 0.765)*
Between-day (run 2) 0.365 (−0.393 to 0.711) −0.124 (−1.466 to 0.488) −0.793 (−2.935 to 0.183) 0.180 (−0.896 to 0.645)
Within-day 1 (run 1/run 2) −0.201 (−1.635 to 0.453) −0.067 (−1.341 to 0.514) 0.025 (−1.248 to 0.533) 0.466 (−0.234 to 0.769)**
Within-day 2 (run 1/run2) 0.172 (−0.818 to 0.622) 0.450 (−0.206 to 0.750)* −0.193 (−1.618 to 0.456) 0.292 (−0.636 to 0.694)
EM Faces> ﬁxation Between-day (both runs) 0.300 (−0.492 to 0.671) −0.502 (−2.200 to 0.295) −0.126 (−1.399 to 0.471) 0.830 (0.607 to 0.926)**
Between-day (run 1) 0.121 (−0.872 to 0.587) 0.176 (−0.754 to 0.613) 0.124 (−1.394 to 0.472) 0.856 (0.666 to 0.938)**
Between-day (run 2) −0.478 (−2.149 to 0.306) −0.283 (−1.733 to 0.397) 0.302 (−0.486 to 0.672) 0.765 (0.458–0.899)**
Within-day 1 (run 1/run 2) −0.240 (−1.641 to 0.418) 0.057 (−1.009 to 0.557) 0.346 (−0.393 to 0.693) 0.897 (0.763–0.956)**
Within-day 2 (run 1/run2) 0.303 (−0.427 to 0.685) 0.321 (−0.446 to 0.681) 0.209 (−0.684 to 0.629) 0.903 (0.775–0.958)**
GC Faces> ﬁxation Between-day (both runs) 0.418 (−0.278 to 0.735)* 0.231 (−0.687 to 0.650) 0.460 (−0.185 to 0.754)* 0.896 (0.759–0.955)**
Between-day (run 1) 0.213 (−0.727 to 0.641) −0.328 (−1.914 to 0.395) 0.473 (−0.156 to 0.760)* 0.854 (0.662–0.937)**
Between-day (run 2) 0.574 (0.066 to −0.806)* 0.552 (0.018–0.796)* 0.041 (−1.104 to 0.563) 0.902 (0.774–0.958)**
Within-day 1 (run 1/run 2) 0.234 (−0.681 to 0.651) −1.190 (−3.806 to 0.002) 0.213 (−0.727 to 0.641) 0.855 (0.664–0.937)**
Within-day 2 (run 1/run2) 0.671 (0.278 to 0.850)* 0.770 (0.495–0.895)* −0.013 (−1.222 to 0.538) 0.948 (0.880–0.977)**
For each functionally-defined region of interest as well as our control region (the right fusiform face area, FFA, defined using a 4 mm sphere around coordinates from a previous
publication (McKeeﬀ and Tong, 2007)), the within-subject reliability of between-day and within-day activation of each task. Between-day reliability is reported averaging across both
runs, and for each run separately. Within-day reliability is reported for day 1 and day 2 separately. A negative ICC is interpreted as indicating a reliability of zero (Bartko, 1976).
GC=gender classiﬁcation; EI=emotion identiﬁcation; EM=emotion matching; LAmyg=left amygdala; RAmyg=right amygdala; sgACC=subgenual anterior cingulate cortex; ICC=inter-
class correlation coeﬃcient; CI=conﬁdence interval.
* ICC > 0.4.
** ICC > 0.75.
Fig. 2. Distribution of parameter estimates for the left amygdala (A) and sgACC (B) in day 1 and day 2 for the gender classiﬁcation task, for the main contrast (faces vs ﬁxation). Note
that for this task, parameter estimates are moderately correlated between scan days in both regions.
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cation task (ICC=0.519, p=0.034, 95%CI=−0.055 to 0.781), the left
amygdala on the second-day in the gender classiﬁcation task
(ICC=0.811, p < 0.001, 95%CI=0.585–0.914), and the right amygdala
on the second day in the emotion identiﬁcation task (ICC=0.523,
p=0.032, 95%CI=−0.047 to 0.783).
Discussion
We observed surprisingly low within-subject reliability of three
putative fMRI biomarkers, the amygdalae and sgACC response to
emotional faces. We identiﬁed just one instance of moderate be-
tween-day reliability (averaged across both runs) that was consistent
between functional and anatomical ROI approaches – in the sgACC on
the gender classiﬁcation task. However, the FFA showed good-to-
excellent between-day reliability in every task. All but one of 18
analyses also showed reliable within-day activity in the FFA. By
contrast, only three (using the functional approach) and ﬁve (using
the anatomical approach) showed at least moderate within-day relia-
bility in the amygdalae and sgACC, with most found on the second day.
There were few substantive diﬀerences between the two ROI
approaches: the anatomical ROI approach yielded ten instances of at
least moderate reliability (out of 45 analyses) and the functional ROI
approach yielded eight (see Tables 3 and 4). In three cases, the same
analyses were reliable using both approaches: the overall between-day
reliability of the sgACC and the within-day reliability (on day 2) of the
left amygdala during the second run (both in the gender classiﬁcation
task); and the within-day reliability (on day 2) of the right amygdala (in
the emotion identiﬁcation task). The remaining analyses diﬀered
between the two approaches. The most notable diﬀerence between
the approaches was that using the functional ROI approach, almost all
instances of reliability occurred in the gender classiﬁcation task; the
anatomical ROI approach produced reliability scores that were more
evenly distributed across the tasks. The anatomical approach also
showed some regional speciﬁcity: seven out of ten instances of
reliability were found in the sgACC. Nonetheless, overall both ap-
proaches revealed generally low reliability.
These ﬁndings have practical implications for studies hoping to use
BOLD responses in these regions as treatment biomarkers in psychia-
try. Our results suggest that many of the task-evoked responses
assumed to be stable within individuals may not in fact be viable
fMRI biomarkers, at least not using these three common paradigms.
They also suggest potentially important task and regional diﬀerences
between functional and anatomical ROI approaches.
Several studies have reported low reliability of amygdala BOLD
responses between two scanning days (Johnstone et al., 2005, Sauder
et al., 2013, Lipp et al., 2014), though it is unexpected that even within
the same scanning session, amygdala response was not particularly
reliable. We are also (to our knowledge) the ﬁrst to speciﬁcally test the
reliability of BOLD responses in the sgACC, a region frequently
identiﬁed in treatment biomarker studies in depression (Keedwell
et al., 2009, 2010, Chen et al., 2007, Davidson et al., 2003). We
suggest that the sgACC and left amygdala response to emotional faces
may be reliable across days under certain conditions, which diﬀer
depending on the task and ROI approach used. However, even in these
circumstances, we found low-to-moderate reliability, just exceeding
our ICC threshold of 0.4, but not ever meeting the threshold for
excellent reliability (ICC > 0.75). Certainly in contrast to the BOLD
response of the FFA, which was ‘excellent’ ( > 0.75) in 10/15 analyses,
the between-day reliability of the amygdalae and sgACC seems
markedly weaker.
It bears mentioning that our anatomical and functional approaches
produced, in most cases, diﬀerent instances of reliability, with the
anatomical approach yielding slightly higher ICCs overall.
Nevertheless, in our results, even the anatomical technique did not
yield high reliability in all, or even most, instances. Overall, our
ﬁndings do not provide strong grounds for optimism for the use of
amygdala or sgACC responses to emotional faces as treatment biomar-
kers (at least on their own: the potential for more complex fMRI
biomarkers, for example using pattern classiﬁcation techniques, re-
mains (Fu et al., 2008a)). Our ﬁndings have signiﬁcant practical
implications for the design and analysis of studies employing putative
fMRI biomarkers: researchers are encouraged to consider region, task,
and ROI selection approaches to develop a useful fMRI biomarker.
Limitations
We selected a priori regions to test that have been strongly
implicated in neurobiological studies of depression and its treatment;
these have often been proposed as potential treatment biomarkers. It is
quite possible that other regions—for example, the dorsolateral pre-
frontal cortex, also implicated in depression (Koenigs and Grafman,
2009)—might show more consistent within-subject reliability than the
amygdalae or sgACC. Indeed, our control analysis of the right FFA
indicates that this region is extremely reliable.
Table 4
Intra-subject reliability statistics for all tasks and contrasts (anatomical ROI).
Task Contrast Reliability LAmyg ICC (95% CI) RAmyg ICC (95% CI) sgACC ICC (95% CI)
EI Faces > ﬁxation Between-day (both runs) 0.190 (−0.777 to 0.631) −0.127 (−1.473 to 0.486) 0.564 (0.043–0.801)*
Between-day (run 1) 0.227 (−0.696 to 0.648) 0.093 (−0.991 to 0.586) 0.297 (−0.543 to 0.680)
Between-day (run 2) 0.175 (−0.811 to 0.624) −0.152 (−0.862 to 0.613) 0.524 (−0.045 to 0.783)*
Within-day 1 (run 1/run 2) 0.235 (−0.678 to 0.651) 0.002 (−1.189 to 0.545) 0.445 (−0.217 to 0.747)*
Within-day 2 (run 1/run2) 0.214 (−0.724 to 0.642) 0.523 (−0.047 to 0.783)* −0.124 (−1.466 to 0.488)
EM Faces > ﬁxation Between-day (both runs) 0.432 (−0.210 to 0.733)* −0.141 (−1.141 to 0.464) 0.326 (−0.435 to 0.684)
Between-day (run 1) 0.090 (0.939 to 0.573) −0.027 (−1.187 to 0.518) 0.445 (−0.197 to 0.744)*
Between-day (run 2) 0.095 (−0.995 to 0.581) 0.013 (−1.102 to 0.537) 0.139 (−0.834 to 0.596)
Within-day 1 (run 1/run 2) 0.053 (−1.018 to 0.555) −0.323 (−1.818 to 0.379) 0.659 (0.274 to 0.840)*
Within-day 2 (run 1/run2) 0.148 (−0.815 to 0.600) 0.137 (−0.837 to 0.595) 0.353 (−0.378 to 0.696)
GC Faces > ﬁxation Between-day (both runs) 0.069 (−1.043 to 0.576) 0.226 (−0.699 to 0.647) 0.577 (0.73–0.807)*
Between-day (run 1) 0.079 (−0.121 to 0.580) 0.112 (−1.440 to 0.493) 0.317 (−0.498 to 0.689)
Between-day (run 2) 0.289 (−0.559 to 0.676) 0.205 (−0.743 to 0.638) 0.205 (−0.743 to 0.638)
Within-day 1 (run 1/run 2) 0.328 (−0.474 to 0.694) 0.256 (−0.632 to 0.661) 0.519 (−0.055 to 0.781)*
Within-day 2 (run 1/run2) 0.811 (0.585 to 0.914)** 0.344 (−0.440 to 0.701) −1.007 (−3.405 to 0.085)
For each anatomically-defined region of interest, the reliability of between-day and within-day activation of each task. Between-day reliability is reported averaging across both runs, and
for each run separately. Within-day reliability is reported for day 1 and day 2 separately. A negative ICC is interpreted as indicating a reliability of zero (Bartko, 1976). GC=gender
classiﬁcation; EI=emotion identiﬁcation; EM=emotion matching; LAmyg=left amygdala; RAmyg=right amygdala; sgACC=subgenual anterior cingulate cortex; ICC=inter-class
correlation coeﬃcient; CI=conﬁdence interval.
* ICC > 0.4.
** ICC > 0.75.
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Our study only tested the reliability of these three regions in a non-
clinical sample of healthy, young individuals. Future studies could
expand our ﬁnding to relevant clinical samples, directly testing the
reliability of putative treatment biomarkers in a population with
neuropsychiatric symptoms. This strategy may yield greater reliability,
as observed, for example, in patients with multiple sclerosis relative to
healthy controls (Bosnell et al., 2008) (note the reverse has also been
shown: regions where healthy controls, but not patients with schizo-
phrenia, show reliable activity (Manoach et al., 2001)). This could be
particularly important with respect to selection of useful fMRI con-
trasts: in our study, as in some previous experiments (Deeley et al.,
2006, Guyer et al., 2008), we failed to ﬁnd amygdala activation in the
fearful-neutral faces contrast, possibly as a result of habituation to the
emotional face stimuli. However, it has also been suggested that
individual diﬀerences in anxiety could account for the degree of
amygdala activation to fearful faces (Calder et al., 2011). Replicating
our study in a clinical population would better clarify which contrasts
are most reliable in neuropsychiatric populations, and better guide
future development of fMRI biomarkers. Furthermore, subclinical
diﬀerences in anxiety and mood state between the scan dates could
account for unreliable neural responses to the emotional stimuli.
Future research should examine the eﬀect of short term (state) and
longer-term (trait) measures of mood and anxiety on the reliability of
BOLD responses in the amygdalae and sgACC.
Future directions
Our results describe an important issue to consider for fMRI
treatment biomarkers, but whether (task-related) fMRI is the optimal
choice for neuroimaging biomarkers still remains to be determined.
Other putative neuroimaging biomarkers have been suggested: resting
state connectivity has been shown to be highly reliable, and is
associated with response to transcranial magnetic stimulation
(Salomons et al., 2014); structural MRI, also highly reliable, when
analysed using machine learning techniques, has successfully predicted
individual response to electroconvulsive therapy (Redlich et al., 2016).
Normalization of sgACC metabolism by antidepressant medication,
measured with positron emission tomography (PET), has also been
proposed as a prerequisite for symptom remission (Mayberg, 2003).
Clinical response to ﬂuoxetine at six weeks was associated with
metabolic decreases in regions including the sgACC, detected after
only one week of treatment; sgACC changes were absent in ﬂuoxetine
non-responders (Mayberg et al., 2000). In a separate study, changes in
sgACC metabolism diﬀerentiated patients who responded to CBT from
those who responded to venlafaxine (Kennedy et al., 2007).
Although structural MRI and PET are not dependent on the
variability of an individual's BOLD response, making these putative
biomarkers potentially more reliable, fMRI is less expensive and far
more commonly-used than PET. Thus, the potential use of fMRI as a
treatment biomarker in depression is more practical than for PET,
providing the incentive for our investigation. As with any methodology,
development of a useable biomarker must ensure test-retest reliability
at the level of the individual: thus, our study might guide future work
towards establishing tasks that evoke more reliable amygdala or sgACC
activation. However, it might also encourage psychiatry researchers to
look outside the most frequently-proposed regions for treatment
biomarkers to those with more reliable BOLD responses.
A ﬁnal suggestion for future research lies in the investigation of
variability itself as a useful marker of susceptibility to emotional
disorders. Habituation of the amygdala to emotional cues has pre-
viously been shown to be a marker of vulnerability to depression (Siegle
et al., 2007, 2002); low and high anxious subjects also show diﬀerences
in amygdala habituation (Sladky et al., 2012). Measures of stability
could therefore contain key information about individual diﬀerences,
which could be employed in clinical studies. This possibility is
strengthened by results from a similar test-retest experiment that
found improved amygdala reliability (particularly in the right amygda-
la) when analysing the habituation, rather than amplitude, of the BOLD
response (Plichta et al., 2012). Future clinical studies (as well as test-
retest studies) would beneﬁt from analysing regional habituation as
well as amplitude in the search of robust, reliable fMRI biomarkers.
This approach might yield more consistent reliability than reported in
our study (Phillips et al., 2001). The search for fMRI biomarkers, then,
requires careful scrutiny of region, task, measure, and analysis, all of
which inﬂuence how stable the BOLD response appears.
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